Prof. Stefan Buchholz to head Evonik's R&D group Creavis


Prof. Stefan Buchholz (50) has assumed the position as head of Creavis, the strategic R&D unit of Evonik. Buchholz studied chemistry in Marburg, Germany and received his doctorate from the Max-Planck Institute of Polymer Research in Mainz. He finished his Post-doc at the Harvard University in Boston, USA. In 2011 Buchholz was appointed honorary professor by the University of Stuttgart. Prof. Buchholz began his professional career within Evonik in 1993 as scientific assistant in the business unit Industry and Fine Chemicals of the former Degussa in Frankfurt. From 1998 to 2000 he worked as plant assistant at the Antwerp, Belgium site before he took over management of the Biotechnology Project House at the Hanau site. From 2008 until recently, Prof. Buchholz was Head of Innovation Management in the business unit Advanced Intermediates.
most read

Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

Novo Nordisk's CEO Lars Fruergaard Jørgensen Steps Down
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.

Oxea Returns to its Roots
Oxea is returning to its old name and its roots.

Supply Chain and Logistics Trends in the Chemical Industry
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.

VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.